Artykuły w czasopismach na temat „Theraputic use”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Theraputic use”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Castro, M. Regina. "Thyroid Nodules—Management Dilemmas and Theraputic Considerations". US Endocrinology 00, nr 01 (2005): 1. http://dx.doi.org/10.17925/use.2005.00.01.1f.
Pełny tekst źródłaCastro, M. Regina. "Thyroid Nodules - Management Dilemmas and Theraputic Considerations". US Endocrinology 00, nr 01 (2005): 68. http://dx.doi.org/10.17925/use.2005.00.01.68.
Pełny tekst źródłaGuancial, Elizabeth A., Vinay S. Mahajan, Ronald P. McCaffrey i Neal Lindeman. "Theraputic Monoclonal Antibody Interference In Immunofixation Electrophoresis". Blood 116, nr 21 (19.11.2010): 4996. http://dx.doi.org/10.1182/blood.v116.21.4996.4996.
Pełny tekst źródłaNeff, Lucas P., Justin M. Allman i James H. Holmes. "The use of theraputic plasma exchange (TPE) in the setting of refractory burn shock". Burns 36, nr 3 (maj 2010): 372–78. http://dx.doi.org/10.1016/j.burns.2009.05.006.
Pełny tekst źródłaPoudel, Parashu Ram. "Physics in Medical Science". Himalayan Physics 2 (31.07.2011): 43–46. http://dx.doi.org/10.3126/hj.v2i2.5210.
Pełny tekst źródłaMueller, Joseph, Ryan Yao, Kim Selting, Catherine Best-Popescu, Brendan Harley i Sara Pedron-Haba. "Abstract A045: Engineered systems for tumor modeling facilitate the assessment of theraputic interventions". Cancer Research 84, nr 5_Supplement_1 (4.03.2024): A045. http://dx.doi.org/10.1158/1538-7445.brain23-a045.
Pełny tekst źródłaAknouk, Mina, i Kenny Chiu. "S2608 Hemospray, a Novel Theraputic Use to Control Rectal Bleeding in a Case of Refractory Hemorrhagic Radiation Proctitis". American Journal of Gastroenterology 117, nr 10S (październik 2022): e1727-e1728. http://dx.doi.org/10.14309/01.ajg.0000867072.17772.0c.
Pełny tekst źródłaMatsumoto, K., H. Kikuchi, S. Kano, H. Iri, H. Takahashi i M. Umino. "Automated determination of drugs in serum by liquid chromatography with column-switching. I. Separation of antiepileptic drugs and metabolites." Clinical Chemistry 34, nr 1 (1.01.1988): 141–44. http://dx.doi.org/10.1093/clinchem/34.1.141.
Pełny tekst źródłaJoshi, SN, M. Chaudhary, D. Bhattarai, S. Gnyawali, G. S. Shrestha i P. Adhikari. "Theraputic application if Poly-2-hydroxy ethyl mathacrylate contact lens in various ocular surface disorders among Nepalese population". Journal of Institute of Medicine Nepal 37, nr 2 (30.08.2015): 35–39. http://dx.doi.org/10.59779/jiomnepal.713.
Pełny tekst źródłaMentrup, Heather, Anna Ramos, Elizabeth Novak, Steven Ballesteros, Erin Crawford, Meredith Flanagan i Kevin Mollen. "MITOCHONDRIAL TURNOVER IS ELEVATED IN RESPONSE TO INTESTINAL INFLAMMATION AND IS AMENABLE TO THERAPUTIC TARGETING VIA UROLITHIN A". Inflammatory Bowel Diseases 30, Supplement_1 (25.01.2024): S3—S4. http://dx.doi.org/10.1093/ibd/izae020.008.
Pełny tekst źródłaJnaidi, Raneem, António José Almeida i Lídia M. Gonçalves. "Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme". Pharmaceutics 12, nr 9 (10.09.2020): 860. http://dx.doi.org/10.3390/pharmaceutics12090860.
Pełny tekst źródłaHuque, Muhammed Moinul, Ashraf Ul Huq, Kaniz Hasina i Md Jafrul Hannan. "Role of laparoscopy in the management of impalpable testis in children: Approach in our country". Journal of Paediatric Surgeons of Bangladesh 8, nr 1 (9.12.2018): 15–19. http://dx.doi.org/10.3329/jpsb.v8i1.69632.
Pełny tekst źródłaMishra, Alka, i Vandana Shrivastava. "Exploring the Science of Marma - An Ancient Healing Technique: Marma Therapy". Dev Sanskriti Interdisciplinary International Journal 22 (4.08.2023): 23–37. http://dx.doi.org/10.36018/dsiij.v20i.157.
Pełny tekst źródłaAlperovich, Michael, Keith M. Blechman, Fares Samra, Richard Shapiro, Deborah M. Axelrod, Mihye Choi, Nolan S. Karp i Amber Azniv Guth. "Nipple-sparing mastectomy and subareolar biopsy: To freeze or not to freeze?" Journal of Clinical Oncology 30, nr 27_suppl (20.09.2012): 185. http://dx.doi.org/10.1200/jco.2012.30.27_suppl.185.
Pełny tekst źródłaGowda, Chandrika S., Chunhua Song, Sunil Muthusami, Yali Ding, Mansi Sachdev, Kimberly Payne i Sinisa Dovat. "Restoring Ikaros Function in Leukemia : Casein Kinase II ( CK2) Inhibition Restores Ikaros Tumor Supressor Function and Shows Theraputic Efficacy in Preclinical Models of High Risk Pediatric Leukemia". Blood 124, nr 21 (6.12.2014): 3712. http://dx.doi.org/10.1182/blood.v124.21.3712.3712.
Pełny tekst źródłaKhillan, Ratesh, Kamudi Somnay i Raj Wadgaonkar. "Therapuetic Use of Alum in Radiation Proctitis". American Journal of Gastroenterology 100 (wrzesień 2005): S283. http://dx.doi.org/10.14309/00000434-200509001-00758.
Pełny tekst źródłaLu, Sydney X., Lucy Willis, Marsinay Smith, David Suh, Christopher King, Johanne Bautista, Melanie Chow i in. "CEACAM-1 Is Involved in Graft-Versus-Host-Disease in Murine Allogeneic Bone Marrow Transplantation Models." Blood 110, nr 11 (16.11.2007): 67. http://dx.doi.org/10.1182/blood.v110.11.67.67.
Pełny tekst źródłaThasneem, K. V. Musaina, K. Sreejith, B. Athulnadh, Namitha Maniyan, Cherakkulath C. Neena i P. P. Muhamed Faris. "SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease". Journal of Drug Delivery and Therapeutics 10, nr 6 (15.11.2020): 203–6. http://dx.doi.org/10.22270/jddt.v10i6.4532.
Pełny tekst źródłaDanon, Limor Meoded, Vanessa Bähr, Elad Schiff, Miriam Ortiz, Benno Brinkhaus i Barbara Stöckigt. "Learning to Establish a Therapeutic Doctor-Patient Communication: German and Israeli Medical Students Experiencing Integrative Medicine’s Skills". Social Science, Humanities and Sustainability Research 2, nr 4 (27.10.2021): p48. http://dx.doi.org/10.22158/sshsr.v2n4p48.
Pełny tekst źródłaAntonelli, Massimo, Giorgio Conti, Andrea Belisari, Lucia S. D'Angiolella, Lorenzo Mantovani, Sabato Montella, Patrizio Piacentini i Marco Ranieri. "The use of dexmedetomidine in intensive care sedation". Farmeconomia. Health economics and therapeutic pathways 14, nr 1S (28.05.2013): 1–28. http://dx.doi.org/10.7175/fe.v14i1s.674.
Pełny tekst źródłaKalra, Kavita B., Xiangfei Cheng, Marion Womak, Christopher Gocke, Jyoti B. Patel, Vincent C. O. Njar i Naoko Takebe. "Novel Retinoic Acid Metabolism Blocking Agents (RAMBAs) Induce Differentiation in ATRA Resistant Cell Line: Potential New Theraputics for Acute Promyleocytic Leukemia (APL)." Blood 106, nr 11 (16.11.2005): 746. http://dx.doi.org/10.1182/blood.v106.11.746.746.
Pełny tekst źródłaInklebarger J, James Inklebarger J., Mr Giles Gyer, Nikiforos Galanis, Mr Jimmy Michael i Dr Ghulam Adel. "Cinchona Bark For The Treatment Of Covid-19 Pnemonia: A Modern Review Of The Potential Anti-Viral Therapuetic Applications Of An Old Treatment". International Journal of Medical Science and Clinical invention 7, nr 05 (1.05.2020): 4795–801. http://dx.doi.org/10.18535/ijmsci/v7i05.02.
Pełny tekst źródłaRiedell, Peter A., Jamie Brower, Loretta Nastoupil, Miguel-Angel Perales, Richard T. Maziarz, Joseph P. McGuirk, Veronika Bachanova i in. "A Multicenter Analysis of Outcomes, Toxicities, and Patterns of Use with Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas". Blood 138, Supplement 1 (5.11.2021): 2512. http://dx.doi.org/10.1182/blood-2021-151971.
Pełny tekst źródłaLalu, Manoj M., Dean A. Fergusson, Wei Cheng, Marc T. Avey, Dale Corbett, Dar Dowlatshahi, Malcolm R. Macleod i in. "Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis". F1000Research 8 (3.01.2019): 11. http://dx.doi.org/10.12688/f1000research.15869.1.
Pełny tekst źródłaSvoboda, Jakub, Hatcher J. Ballard, Carrie I. Ho, Mitchell E. Hughes, Elise A. Chong, Adam Duca, Sara Prischak i in. "Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors". Blood 138, Supplement 1 (5.11.2021): 2445. http://dx.doi.org/10.1182/blood-2021-153122.
Pełny tekst źródłaJones, J. A., J. Flynn, M. Moran, T. Lin i J. Byrd. "Trends in pneumonia (PNA) hospitalization among patients (pts) with chronic lymphocytic leukemia (CLL)". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): e20500-e20500. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e20500.
Pełny tekst źródłaGordeuk, Victor R., Barbara Kroner, Norma Pugh, Jane S. Hankins, Abdullah Kutlar, Allison A. King, Nirmish Shah, Julie Kanter, Jeffrey Glassberg i Marsha Treadwell. "Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease". Blood 136, Supplement 1 (5.11.2020): 33. http://dx.doi.org/10.1182/blood-2020-143315.
Pełny tekst źródłaChristopoulos, Georgios, Zachi I. Attia, Peter A. Noseworthy, Timothy G. Call, Wei Ding, Jose F. Leis, Eli Muchtar i in. "Use of Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation (AF) in Patients with Chronic Lymphocytic Leukemia (CLL)". Blood 136, Supplement 1 (5.11.2020): 50–51. http://dx.doi.org/10.1182/blood-2020-142645.
Pełny tekst źródłaCarniti, Cristiana, Chiara Monfrini, Vanessa Aragona, Martina Magni, Cristina Vella, Eugenio Fardella, Riccardo Betta i in. "Tisagenlecleucel and Axicabtagene Ciloleucel Expansion Kinetics and CAR T Cell Attributes in the Infusion Products Are Early Predictors of Clinical Efficacy". Blood 138, Supplement 1 (5.11.2021): 3877. http://dx.doi.org/10.1182/blood-2021-152309.
Pełny tekst źródłaThompson, Meghan C., Lindsey E. Roeker, Catherine C. Coombs, Jeffrey L. Jensen, Manali Kamdar, Alan Skarbnik, John M. Pagel i in. "Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton's Tyrosine Kinase Inhibitor and Venetoclax". Blood 138, Supplement 1 (5.11.2021): 2628. http://dx.doi.org/10.1182/blood-2021-150751.
Pełny tekst źródłaGlaspy, John, Tom Tang, Dean Rutty, Xiaoqiang Yan, Igor Bondarenko i Dmitrii Krasnozhon. "A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 (benefilgrastim) in Women with Breast Cancer Receiving Myelotoxic Chemotherapy". Blood 124, nr 21 (6.12.2014): 1584. http://dx.doi.org/10.1182/blood.v124.21.1584.1584.
Pełny tekst źródłaKuruvilla, Philip, Juhi Husain, Henry J. Conter, William To-Dang, Margaret Balcewicz i Stephen Reingold. "Real World Experience of Ibrutinib in an Ethnically Diverse Canadian Community Hospital". Blood 142, Supplement 1 (28.11.2023): 6549. http://dx.doi.org/10.1182/blood-2023-172977.
Pełny tekst źródłaDiamond, Akiva, Sabarish Ayyappan, Shufen Cao, Nour Tashtish, Kirsten M. Boughan, Brenda W. Cooper, Pingfu Fu i Paolo F. Caimi. "Development of a Risk Score for Cardiovascular Events in Anthracycline Treated DLBCL Patients". Blood 138, Supplement 1 (5.11.2021): 2536. http://dx.doi.org/10.1182/blood-2021-153862.
Pełny tekst źródłaAmonoo, Hermioni L., Areej El-Jawahri, Thomas W. LeBlanc, Alison R. Kavanaugh, Jason A. Webb, Lara Traeger, Annemarie D. Jagielo i in. "Post-Traumatic Stress Disorder (PTSD) Symptoms in Patients with Acute Myeloid Leukemia (AML)". Blood 136, Supplement 1 (5.11.2020): 44–45. http://dx.doi.org/10.1182/blood-2020-133857.
Pełny tekst źródłaSaultz, Jennifer N., Kaycee Moshofsky, Andy Kaempf, Guang Fan, Gabrielle Meyers, Rachel J. Cook, Richard T. Maziarz, Peggy Appel, Francisco Tria i Staci Williamson. "Early Infection after Allogeneic Transplant Increases NRM without Influencing Relapse Rate". Blood 136, Supplement 1 (5.11.2020): 21. http://dx.doi.org/10.1182/blood-2020-142048.
Pełny tekst źródłaMasese, Rita V., Dominique Bulgin, Mitchell Knisely, Liliana Preiss, Eleanor Stevenson, Jane S. Hankins, Marsha Treadwell i in. "Sex Based Differences in Sickle Cell Disease". Blood 136, Supplement 1 (5.11.2020): 37. http://dx.doi.org/10.1182/blood-2020-140896.
Pełny tekst źródłaHeitzer, Andrew M., Jennifer Longoria, Evadnie Rampersaud, Sara Rashkin, Jeremie H. Estepp, Victoria Okhomina, Winfred Wang i in. "Fetal Hemoglobin Mediates the Effect of Beta Globin Gene Polymorphisms on Neurocognitive Functioning in Sickle Cell Disease". Blood 136, Supplement 1 (5.11.2020): 23–24. http://dx.doi.org/10.1182/blood-2020-137065.
Pełny tekst źródłaMasese, Rita V., Dominique Bulgin, Liliana Preiss, Mitchell Knisely, Eleanor Stevenson, Jane S. Hankins, Marsha Treadwell i in. "Predictors of Maternal Morbidity Among Participants Enrolled in the Sickle Cell Disease Implementation Consortium Registry". Blood 136, Supplement 1 (5.11.2020): 3. http://dx.doi.org/10.1182/blood-2020-140743.
Pełny tekst źródłaWang, Zhiquan, Justin C. Boysen, Huihuang Yan, Charla R. Secreto, Sameer A. Parikh, Saad S. Kenderian, Wei Ding, Esteban Braggio, Susan L. Slager i Neil E. Kay. "Targeting Aberrant Chromatin in Chronic Lymphocytic Leukemia". Blood 136, Supplement 1 (5.11.2020): 1. http://dx.doi.org/10.1182/blood-2020-140309.
Pełny tekst źródłaHampel, Paul J., Sameer A. Parikh, Timothy G. Call, Mithun Vinod Shah, Nabila Bennani, Aref Al-Kali, Kari G. Rabe i in. "Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia". Blood 136, Supplement 1 (5.11.2020): 39–40. http://dx.doi.org/10.1182/blood-2020-134586.
Pełny tekst źródłaCosta, Luciano J., Sandy W. Wong, Arancha Bermúdez, Javier de la Rubia, María-Victoria Mateos, Enrique M. Ocio, Paula Rodríguez-Otero i in. "First Clinical Study of the B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager (TCE) CC-93269 in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Interim Results of a Phase 1 Multicenter Trial". Blood 134, Supplement_1 (13.11.2019): 143. http://dx.doi.org/10.1182/blood-2019-122895.
Pełny tekst źródłaAbrisqueta, Pau, Juan-Manuel Sancho, Raul Cordoba, Daniel O. Persky, Charalambos Andreadis, Scott F. Huntington, Cecilia Carpio i in. "Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)". Blood 134, Supplement_1 (13.11.2019): 4089. http://dx.doi.org/10.1182/blood-2019-125310.
Pełny tekst źródłaFoster, Matthew C., Philip A. Roehrs, George E. Hucks, Natalie S. Grover, Paul M. Armistead, Katarzyna Jamieson, Faith Brianne Buchanan i in. "Safety and Antitumor Effects of CD19-Specific Autologous Chimeric Antigen Receptor-Modified T (CAR-T) Cells Expressing the Inducible Caspase 9 Safety Switch (iC9-CAR19 T Cells) in Adult Acute Lymphoblastic Leukemia (ALL)". Blood 136, Supplement 1 (5.11.2020): 36–37. http://dx.doi.org/10.1182/blood-2020-139051.
Pełny tekst źródłaKamdar, Manali, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi i in. "Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy, Versus Standard of Care (SOC) with Salvage Chemotherapy (CT) Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Randomized Phase 3 Transform Study". Blood 138, Supplement 1 (5.11.2021): 91. http://dx.doi.org/10.1182/blood-2021-147913.
Pełny tekst źródłaZeidan, Amer M., Daniel J. DeAngelo, Jeanne M. Palmer, Christopher S. Seet, Martin S. Tallman, Xin Wei, Ying Fei Li i in. "A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results". Blood 134, Supplement_1 (13.11.2019): 1320. http://dx.doi.org/10.1182/blood-2019-125363.
Pełny tekst źródłaBishop, Michael R., Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato i in. "Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study". Blood 138, Supplement 2 (4.12.2021): LBA—6—LBA—6. http://dx.doi.org/10.1182/blood-2021-155068.
Pełny tekst źródłaConnor, John, Fredrick Rappaport i Ihor S. Sawczuk. "Results with the Use of MVAC in Theraputic and Adjunctive Settings". Journal of Urology 137, nr 6 (czerwiec 1987). http://dx.doi.org/10.1016/s0022-5347(17)75812-0.
Pełny tekst źródłaThakur, Santosh Kumar, Sumit Natthani i Mita Kotecha. "PRIMITIVE THERAPUTIC BIDS OF MEDICINAL PLANT ROHITAKATECOMELLA UNDULATA (SM.) SEEM.: A COMPREHENSIVE APPRAISAL BASED ON CLASSICAL AYURVEDA TEXTS". GLOBAL JOURNAL FOR RESEARCH ANALYSIS, 15.08.2020, 17–20. http://dx.doi.org/10.36106/gjra/5603204.
Pełny tekst źródłaLi, Yimin, Yonglin Yi, Anqi Lin, Peng Luo i Jian Zhang. "A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis". Cancer Cell International 20, nr 1 (10.11.2020). http://dx.doi.org/10.1186/s12935-020-01639-4.
Pełny tekst źródłaOnallah, Hadil, Ronen Hazan i Ran Nir-Paz. "2142. The use of Pseudomonas aeruginosa Phage PASA16 for non resolving infections". Open Forum Infectious Diseases 10, Supplement_2 (27.11.2023). http://dx.doi.org/10.1093/ofid/ofad500.1765.
Pełny tekst źródła